These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 20031628)

  • 81. High on-clopidogrel platelet reactivity: genotyping can help to optimize antiplatelet treatment.
    Szymezak J; Moreau C; Loriot MA; Durand E; Van Viet H; Desnos M; Gaussem P
    Thromb Res; 2011 Jul; 128(1):92-5. PubMed ID: 21349573
    [No Abstract]   [Full Text] [Related]  

  • 82. Clopidogrel pharmacogenetics and its clinical implications.
    Singh M; Thapa B; Arora R
    Am J Ther; 2010; 17(3):e66-73. PubMed ID: 19636246
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The impact of generic clopidogrel bisulfate on platelet inhibition in patients with coronary artery stents: results of the ACCEL-GENERIC study.
    Jeong YH; Koh JS; Kang MK; Ahn YJ; Kim IS; Park Y; Hwang SJ; Kwak CH; Hwang JY
    Korean J Intern Med; 2010 Jun; 25(2):154-61. PubMed ID: 20526388
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Impact of chronic kidney disease on platelet reactivity and outcomes of patients receiving clopidogrel and undergoing percutaneous coronary intervention.
    Mangiacapra F; Cavallari I; Barbato E; Ricottini E; Patti G; Vizzi V; D'Ambrosio A; De Bruyne B; Wijns W; Di Sciascio G
    Am J Cardiol; 2014 Apr; 113(7):1124-9. PubMed ID: 24507863
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Considerable variability in platelet activity among patients with coronary artery disease in response to an increased maintenance dose of clopidogrel.
    Oestreich JH; Holt J; Dunn SP; Smyth SS; Campbell CL; Charnigo R; Akers WS; Steinhubl SR
    Coron Artery Dis; 2009 May; 20(3):207-13. PubMed ID: 19318928
    [TBL] [Abstract][Full Text] [Related]  

  • 86. High loading dose of clopidogrel is unable to satisfactorily inhibit platelet reactivity in patients with glycoprotein IIIA gene polymorphism: a genetic substudy of PRAGUE-8 trial.
    Motovska Z; Widimsky P; Kvasnicka J; Petr R; Bilkova D; Hajkova J; Marinov I; Simek S; Kala P;
    Blood Coagul Fibrinolysis; 2009 Jun; 20(4):257-62. PubMed ID: 19530321
    [TBL] [Abstract][Full Text] [Related]  

  • 87. A head-to-head comparison between the VerifyNow P2Y12 assay and light transmittance aggregometry for monitoring the individual platelet response to clopidogrel in patients undergoing elective percutaneous coronary intervention.
    van Werkum JW; van der Stelt CA; Seesing TH; Hackeng CM; ten Berg JM
    J Thromb Haemost; 2006 Nov; 4(11):2516-8. PubMed ID: 16938130
    [No Abstract]   [Full Text] [Related]  

  • 88. P2RY1 and P2RY12 polymorphisms and on-aspirin platelet reactivity in patients with coronary artery disease.
    Timur AA; Murugesan G; Zhang L; Aung PP; Barnard J; Wang QK; Gaussem P; Silverstein RL; Bhatt DL; Kottke-Marchant K
    Int J Lab Hematol; 2012 Oct; 34(5):473-83. PubMed ID: 22574824
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Intra-individual variability of residual platelet reactivity assessed by the VerifyNow-P2Y12 assay in patients with clopidogrel resistance after percutaneous coronary intervention.
    Ahn SG; Lee SH; Sung JK; Kim JY; Yoon J
    Platelets; 2011; 22(4):305-7. PubMed ID: 21480769
    [No Abstract]   [Full Text] [Related]  

  • 90. Pharmacogenomics of anti-platelet therapy focused on peripheral blood cells of coronary arterial disease patients.
    Luchessi AD; Silbiger VN; Hirata RD; Lima-Neto LG; Cavichioli D; Iñiguez A; Bravo M; Bastos G; Sousa AG; Brión M; Carracedo A; Hirata MH
    Clin Chim Acta; 2013 Oct; 425():9-17. PubMed ID: 23832067
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Association between P2RY12 gene polymorphisms and adverse clinical events in coronary artery disease patients treated with clopidogrel: A systematic review and meta-analysis.
    Li JL; Fu Y; Qin SB; Liang GK; Liu J; Nie XY; Chen J; Shi LW; Shao H; Lu Y
    Gene; 2018 May; 657():69-80. PubMed ID: 29510176
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Study of the Association of PEAR1, P2Y12, and UGT2A1 Polymorphisms with Platelet Reactivity in Response to Dual Antiplatelet Therapy in Chinese Patients.
    Zhang S; Zhu J; Li H; Wang L; Niu J; Zhu B; He L; Shen L; Qin S; Fang S
    Cardiology; 2018; 140(1):21-29. PubMed ID: 29635252
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Variability of residual platelet function despite clopidogrel treatment in patients with peripheral arterial occlusive disease.
    Linnemann B; Schwonberg J; Toennes SW; Mani H; Lindhoff-Last E
    Atherosclerosis; 2010 Apr; 209(2):504-9. PubMed ID: 20153859
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Associations between P2RY12 gene polymorphisms and risks of clopidogrel resistance and adverse cardiovascular events after PCI in patients with acute coronary syndrome.
    Li M; Wang H; Xuan L; Shi X; Zhou T; Zhang N; Huang Y
    Medicine (Baltimore); 2017 Apr; 96(14):e6553. PubMed ID: 28383427
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Platelet reactivity in patients carrying the e-NOS G894T polymorphism after a loading dose of aspirin plus clopidogrel.
    Strisciuglio T; Di Gioia G; Mangiacapra F; De Biase C; Delrue L; Pellicano M; Bartunek J; Vanderheyden M; Izzo R; Trimarco B; Wijns W; Barbato E
    Thromb Res; 2017 Mar; 151():72-73. PubMed ID: 28160671
    [No Abstract]   [Full Text] [Related]  

  • 96. The relevance of P2Y(12)-receptor gene variation for the outcome of clopidogrel-treated patients undergoing elective coronary stent implantation: a clinical follow-up.
    Bouman HJ; van Werkum JW; Rudež G; Hackeng CM; Leebeek FW; ten Cate H; ten Berg JM; de Maat MP
    Thromb Haemost; 2012 Jan; 107(1):189-91. PubMed ID: 22159428
    [No Abstract]   [Full Text] [Related]  

  • 97. The Cone-and-Plate(let) analyzer is not suitable to monitor clopidogrel therapy: a comparison with the flowcytometric VASP assay and optical aggregometry.
    van Werkum JW; Bouman HJ; Breet NJ; ten Berg JM; Hackeng CM
    Thromb Res; 2010 Jul; 126(1):44-9. PubMed ID: 20452655
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Differences in high on-treatment platelet reactivity between intra-coronary and peripheral blood after dual anti-platelet agents in patients with coronary artery disease.
    Hu YF; Lu TM; Wu CH; Lin YJ; Chang SL; Lo LW; Tuan TC; Chao TF; Chung FP; Liao JN; Tzeng CH; Chen SA; Tsao HM
    Thromb Haemost; 2013 Jul; 110(1):124-30. PubMed ID: 23677387
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Does hemodialysis affect clopidogrel resistance as measured by VerifyNow P2Y12 test?
    Geara AS; Ayoub I; Abi Rached J; Siddique MN; Ghimire P; El-Sayegh S
    Am J Cardiol; 2011 Apr; 107(7):1103-4. PubMed ID: 21419895
    [No Abstract]   [Full Text] [Related]  

  • 100. C3435T polymorphism of the ABCB1 gene is associated with poor clopidogrel responsiveness in a Mexican population undergoing percutaneous coronary intervention.
    Calderón-Cruz B; Rodríguez-Galván K; Manzo-Francisco LA; Vargas-Alarcón G; Fragoso JM; Peña-Duque MA; Reyes-Gómez CA; Martínez-Ríos MA; De la Peña-Díaz A
    Thromb Res; 2015 Nov; 136(5):894-8. PubMed ID: 26362473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.